CSIMarket


Kamada Ltd   (KMDA)
Other Ticker:  
 

Kamada Ltd

KMDA's Fundamental analysis








Looking into Kamada Ltd growth rates, revenue grew by 24.79 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1575

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.79 %



More on KMDA's Growth


Kamada Ltd
realized net loss in trailing twelve months.

Kamada Ltd realized cash outflow of $ 0per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 1.56.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.45.


More on KMDA's Valuation
 
 Total Debt (Millions $) 37
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.75
 Tangible Book Value (Per Share $) 3.79

Kamada Ltd
realized net loss in trailing twelve months.

Kamada Ltd realized cash outflow of $ 0per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 1.56.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.45.

Kamada Ltd Price to Book Ratio is at 1.15 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

More on KMDA's Valuation

  Market Capitalization (Millions $) 202
  Shares Outstanding (Millions) 46
  Employees -
  Revenues (TTM) (Millions $) 129
  Net Income (TTM) (Millions $) -2
  Cash Flow (TTM) (Millions $) -
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) 37
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.75
  Tangible Book Value (Per Share $) 3.79

  Market Capitalization (Millions $) 202
  Shares Outstanding (Millions) 46
  Employees -
  Revenues (TTM) (Millions $) 129
  Net Income (TTM) (Millions $) -2
  Cash Flow (TTM) (Millions $) -
  Capital Exp. (TTM) (Millions $) -